<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">337061</id>
  <title nil="true"/>
  <common-name>2-[2-[(8s,9s,10r,13s,14s,17r)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl]sulfanylacetic acid</common-name>
  <description>2-[2-[(8s,9s,10r,13s,14s,17r)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl]sulfanylacetic acid is a compound with the formula C23H30O6S. It has an average molecular weight of 434.50 g/mol.</description>
  <cas>114223-07-3</cas>
  <pubchem-id>13989640</pubchem-id>
  <chemical-formula>C23H30O6S</chemical-formula>
  <weight>434.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T19:46:05Z</created-at>
  <updated-at type="dateTime">2026-08-30T19:46:05Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CSCC(=O)O)O)C</moldb-smiles>
  <moldb-formula>C23H30O6S</moldb-formula>
  <moldb-inchi>InChI=1S/C23H30O6S/c1-21-7-5-14(24)9-13(21)3-4-15-16-6-8-23(29,18(26)11-30-12-19(27)28)22(16,2)10-17(25)20(15)21/h9,15-16,20,29H,3-8,10-12H2,1-2H3,(H,27,28)/t15-,16-,20+,21-,22-,23-/m0/s1</moldb-inchi>
  <moldb-inchikey>IWKCRBDVDSOWKC-RVVAPLPOSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">434.1763099</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>1.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM332954</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[2-[(8s,9s,10r,13s,14s,17r)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl]sulfanylacetic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Steroids and steroid derivatives</klass>
  <subklass>Pregnane steroids</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0287509</sync-id>
  <structure-inchikey>IWKCRBDVDSOWKC-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000000898000000900000000000000020000000000000020000000000000000020000000000000200004000080000400000000000100000080010040000000000000000000000200000020000000000000000000000000000000000000010000000040000000001000000000020008004000000000000000100000000048000000000000000000000020200004000000001000000000000020020000110004000000000000080000000008000800000000000000000000001000000000000100000800000000000000000000010000000000600000200000000000000000000000000040080000000400000000010008000004000010000000</structure-fingerprint>
  <structure-pattern-fingerprint>701640008532866089585b65c1a8b3081a0014129107a010803d60408a24484c6c22001013a0000c0140410a80c00060056002ac428f323120ae6539c2a0411ccf118c8c1290140300921060127263006804c58151615e374204456240225b85cc78452f104c322860aa8480ddb40048308682528105e506110a2c70a2510906504410294efca6080c0603d0c82c0288391d8a7644429ec250240c2060c440c545d190b009b2d3a20307496a816cb5140ec10083a94108c018b04ab00cc00212a20110a4e494023319c0c4e2d71502910c056030032470208d5026062a00c30291386d741889413011048401d196a0860e50063090c2050f13081300d6020a02</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAeAAAAIQAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:38:17Z</structure-indexed-at>
</compound>
